T he TCR of CD8
ϩ T lymphocytes interfaces with an antigenic structure comprising a short peptide, normally 8 -10 aa in length, embedded in a MHC class I molecule. Conserved interactions by the class I ␣ helices and the complementarity-determining region 1 of the TCR provide a framework in which the TCR lies diagonally across the peptide-binding cleft, whereas the complementarity-determining region 3 contacts the center of the bound peptide (1) . Most of the surface area of the peptide, particularly the N and C termini, is buried within the cleft of the peptide-binding region of class I molecules and is thus inaccessible for direct contact with the TCR (2-4). Peptide discrimination by the TCR has been suggested to be mediated by one, or a few, central amino acid side chains pointing toward the TCR, thus providing the "primary TCR contact" residues (3, 5) , whereas a TCR can often tolerate substantial differences in the remainder of the peptide and still deliver activation signals (6 -11) , and in some cases T cell clones have been shown to recognize determinants even without primary sequence homology with the cognate determinant (12) (13) (14) (15) . The limited direct interaction and the generally poor structural complementarity of the TCR-peptide-MHC interface may provide an explanation for the observed degeneracy of T cell recognition (16) . Alternatively, it has been suggested that the TCR may recognize conformational changes in the class I molecule itself as a consequence of diverse peptide binding (17) .
(Canberra, Australia). Mice were immunized with virus at the age of 6 wk or older.
Viruses
Working stocks of MVE (prototype strain MVE-1-51), WNV (Sarafend strain), kunjin (KUN) (MRM16), and JE (Nakayama strain) were 10% suckling mouse brain homogenates in HBSS (pH 8.0) supplemented with 0.2% BSA (31) . Virus stocks were titrated by plaque formation on Vero cell monolayers (32) . Vaccinia virus (VV) recombinant, VV-C.NP 50 -57 / 1785, encodes peptides NP 50 -57 (from influenza A virus nucleoprotein) and MVE 1785 downstream from the signal peptidase cleavage site of the membrane-anchored form of the MVE capsid protein (33) . This results in targeting of the tandem peptide into the lumen of the endoplasmic reticulum and efficient presentation of peptide MVE 1785 due to its COOH-terminal location (33) . Crude VV stocks were prepared from infected CV1 cell lysates (34) . Adenovirus type 5 (35), Semliki Forest virus (SFV) (36) , the influenza viruses A/Pr8 and B/Lee (37) , and Sendai virus (38) were grown and titrated as has been described. 
Cells

Synthetic peptides
The amino acid sequences of synthetic peptides used in this study are shown in Tables I and IV and were synthesized by the Biomolecular Resource Facility in the John Curtin School of Medical Research. Peptides were dissolved at 10 Ϫ3 M in 0.1 M HEPES buffer (pH 7.4) containing 5% DMSO. The final DMSO concentration used did not increase spontaneous 51 Cr release in cytotoxicity assays (data not shown). A database search was performed for mouse sequences conforming to the sequence motifs x(ED)Hx(GA)x(ED)(VI) and x(ED)(GA)xxx(VAI)(VI), using the PeptideSearch tool (http://www.mann.embl-heidelberg.de/Services/PeptideSearch/PeptideSearchIntro.html). The peptides shown in Table IV were purchased as PepSet from Chiron Technologies (Melbourne, Australia). Individual peptides were dissolved based on the estimated yield as above. Single letter amino acid codes are used in sequence comparisons.
MHC class I stabilization assay
The MHC class I stabilization assays were performed essentially as described (40) . T2.K k cells were cultured overnight at 26°C, then incubated in the presence of indicated concentrations of peptide for another 12 h at 26°C. Cells were washed in PBS/BSA (1%) and treated with H-2K k -specific mAb TIB-95 (American Type Culture Collection (ATCC), Manassas, VA) at saturating concentrations for 30 min at 4°C. After washing twice, the cells were stained with FITC sheep anti-mouse mAb (Silenus, Melbourne, Australia) for 30 min at 4°C. Analysis of the surface fluorescence of live cells was performed on a Becton Dickinson FACScan (Becton Dickinson, Franklin Lakes, NJ). Fluorescence index (FI) was calculated as (mean fluorescence with peptide)/(mean fluorescence without peptide). FI 50 is given as the peptide concentration that yields 50% optimal K k up-regulation.
For the determination of half-lives of peptide-K k complexes, T2.K k cells were loaded with peptide (10 Ϫ4 M) as described above, washed twice, and then chased at 37°C. At different time points (0 -9 h), aliquots were removed and kept on ice until the end of the assay, when they were labeled for K k as above. During storage on ice, no increase of constitutive surface K k expression was observed (data not shown).
Generation of effector Tc cells
CBA/H mice were immunized i.p. with flavivirus (5 ϫ 10 6 PFU). Spleens from primed mice were harvested 6 -8 days or 2-10 weeks (for memory Tc cells) later, and single cell suspensions were prepared. For restimulation with virus, one-fifth of the spleen cell suspensions were infected with flavivirus for 1 h at a multiplicity of 5 PFU/cell, washed, and cultured with the rest of the splenocytes for 5 day in Eagle's minimal essential medium supplemented with 10% FCS and 10 Ϫ4 M 2-ME (culture medium). For restimulation with peptide, one-fifth of the spleen cell suspensions were pulsed for 1 h with 10 Ϫ4 M peptide, washed, and cultured with the rest of the splenocytes for 5 day. MVE-primed splenocytes restimulated in vitro with virus or peptide are designated anti-virus or anti-peptide Tc cells. Also, the two groups of flavivirus-derived peptides are designated 1785 peptides (those with sequences corresponding to MVE [1785] [1786] [1787] [1788] [1789] [1790] [1791] [1792] ) and 1971 peptides (those with sequences corresponding to MVE [1971] [1972] [1973] [1974] [1975] [1976] [1977] [1978] [1979] ). 51 Cr release cytotoxicity assay 2R target cells were infected with flavivirus for 24 h, or incubated in medium only (mock), using 50 PFU/cell and labeled with 51 Cr for 1 h. T2.K k target cells were labeled with 51 Cr for 1 h followed by treatment with peptide (10 Ϫ4 M) for 1 h. Targets were washed three times with culture medium and cocultured with titrated numbers of effector cells for 6 h. All assays were performed in triplicate in 96-well plates; SEM was never greater than 5% and medium release was never greater than 22%. Target cells were infected with adenovirus type 5 (35) , SFV (36) , the influenza viruses A/Pr8 and B/Lee (37) , and Sendai virus (38) and labeled with 51 Cr as has been described.
Staining for intracellular IFN-␥
MVE-primed mice (5 ϫ 10 6 PFU) were challenged 5 wk later with 5 ϫ 10 7 PFU VV-C.NP 50 -57 /1785. Four days after challenge, splenocytes were isolated and red cell-depleted, using a Ficoll gradient. Cell populations were incubated at 5 ϫ 10 5 /200 l in 96-well plates with or without peptide (5 ϫ 10 Ϫ5 M) for 6 h, in culture medium supplemented with 10% supernatant from the IL-2-secreting cell line ␣6310 (ATCC) and 10 g/ml brefeldin A (BFA; Sigma, St. Louis, MO). After culture, cells were washed twice in ice-cold PBS containing BFA (10 g/ml) and stained with rat anti-mouse CD8-PE mAb (PharMingen, San Diego, CA) for 30 min at 4°C. After washing in PBS/BFA, cells were fixed in 2% paraformaldehyde in PBS for 30 min at 4°C. Paraformaldehyde was then washed off and cells were permeabilized in PBS with 0.5% saponin (PBS/saponin; Sigma) for 10 min at room temperature and labeled with rat anti-mouse IFN-␥-FITC mAb (PharMingen) in PBS/saponin for 30 min at 4°C. Analysis was performed on a Becton Dickinson FACScan. Lymphocyte populations were gated for CD8 ϩ cells and assessed for FITC fluorescence. CD8 ϩ cells from naive animals incubated with peptide always stained Ͻ0.5% positive for IFN-␥.
Results
Flavivirus-immune Tc cells are broadly flavivirus cross-reactive
Tc cell populations raised against one flavivirus are cross-reactive against targets infected by a number of other flaviviruses (24 -28) . Fig. 1 shows an example lysis of target cells infected with the homologous or heterologous flaviviruses by secondary in vitro flavivirus-immune Tc cells from CBA/H mice (H-2 k ). All four viruses used are members of the JE-serocomplex (41) . MVE and WNV generated the strongest Tc cell responses in vitro and displayed a similar hierarchy of lytic activity against target cells infected with heterologous flaviviruses: MVE-and WNV-infected targets were lysed most efficiently, followed by KUN-and JEinfected targets. Mock-infected target cells were also lysed, particularly by anti-MVE and anti-KUN Tc cells (42) . Lysis of target cells infected with the virus used for priming was not necessarily the most efficient, possibly because of the differential infectivity of target cells by the various virus preparations. Anti-JE Tc cells gave only weak lysis of flavivirus-infected target cells (25) and were least discriminatory in the recognition of heterologous viruses. The only Tc cell population that did not recognize all of the tested viruses were anti-KUN effectors, which only lysed MVE-, WNV-, and KUN-, but not JE-infected targets above the level of mockinfected target cells.
Sequence alignment of putative flaviviral Tc cell determinants with immunodominant determinants from MVE
We have identified two peptide determinants (MVE 1785 (Table I ). Both determinants are derived from the flaviviral NS3 protein. All but one of the peptides contain the anchor residues constituting the K k binding motif: Glu or Asp at position 2 and Ile or Val at the C terminus (44) . YF 1785 is an exception with the acidic Glu of MVE 1785 at position 2 substituted by a large nonpolar His, a residue likely to interfere with binding to K k . Consistent with their antigenic and genetic relatedness, the peptides from viruses of the JE serocomplex have higher homology to MVE 1785 and MVE 1971 (two or fewer amino acid differences) than YF and DEN (three or more amino acid differences). Also shown in Table I is the sequence of an H-2K k -restricted Tc cell determinant from influenza virus nucleoprotein (NP 50 -57 ) (45), which was used as a control peptide.
Peptide affinity for K k of peptide-K k complexes
To evaluate the relative affinities of the peptides for H-2K k , MHC class I stabilization assays were performed using human T2 cells stably transfected with H-2K k (39) . This cell line has low MHC class I cell surface expression (46) due to a deletion of the peptide transporter genes required for efficient MHC class I Ag presentation (47) . Exogenously added K k -binding peptides can increase K k cell surface expression, which can be measured by flow cytometry.
The ability to stabilize K k varied substantially between the peptides tested (Table I) . YF 1785 was the peptide with the lowest affinity, which is likely due to the nonconservative amino acid substitution from Glu to His at the K k anchor at position 2. DEN 1971 also had low affinity for K k . The strongest binding peptide was KUN 1971 . WNV 1971 and JE 1971 also had high affinity, whereas the other six peptides were of intermediate affinity. At 10 Ϫ4 M all peptides induced optimal up-regulation (FI ϭ 11-12), except YF 1785 (FI ϭ 4.8) and DEN 1971 (FI ϭ 6.2). A concentration of 10 Ϫ4 M was used for peptide loading of target cells in cytotoxicity assays throughout this study, unless stated otherwise.
Because the off-rate of the peptide from the restriction element is thought to provide a better estimate of its immunogenicity than affinity (48), we also chased peptide-pulsed T2.K k cells at 37°C to assess the stability of the peptide-K k complexes on the cell surface. According to this criterion, the peptides can be divided into three groups: two peptides, YF 1971 and DEN 1971 have very low peptide-K k half-lives (Ͻ30 min), and the DEN 1971 peptide also had a weak overall affinity for K k . Half-lives of medium duration (2.9 -5.4 h) were found for YF 1785 and for the two MVE-derived peptides, whereas all other peptides gave half-lives in excess of 8 h. Surprisingly, YF 1785 -K k complexes were found to have a half-life of medium duration (3.1 h), indicating a comparatively slow offrate of this peptide lacking the binding motif for H-2K k .
Flavivirus-immune Tc cells recognize homologous peptide determinants
To analyze the molecular basis of cross-reactivities in the flavivirus-immune K k -restricted Tc cell response, 2R target cells were treated with MVE 1785 , MVE 1971 , or the corresponding homologous flavivirus-derived peptides. Recognition of peptide-pulsed target cells by three secondary in vitro virus-stimulated (8 day postinfection) Tc cell effectors (anti-MVE, anti-WNV, and anti-KUN) was tested (Table II) . Anti-MVE and anti-WNV Tc cells showed an almost identical recognition pattern for target cells treated with the 1785 peptides, with high lysis against MVE 1785 , KUN 1785 , and JE 1785 , and some recognition of DEN 1785 and YF 1785 (which binds only weakly to K k ). This recognition pattern 
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a The ability to upregulate K k is given as FI 50 , the concentration of peptide required for 50% of optimal H-2K k -upregulation. Data are interpolated (not labeled) or extrapolated (labeled ‡) from a three-point logarithmic regression. All regressions yielded correlation coefficients r Ն 0.9. Representative data from one of two experiments are shown.
b t 1/2 is the half-life of TIB-95-labeled peptide-K k complexes on T2.K k cells loaded at 26°C with peptide (10 Ϫ4 M) and then chased at 37°C. Values are interpolated (not labeled) or extrapolated (labeled ‡) after logarithmic regression of a seven-point curve (0 -9 h). yielded effectors with a reactivity pattern very similar to that obtained with MVE 1785 (Table III) . DEN 1785 stimulation gave effectors that also efficiently recognized all 1785 peptides, but with less clear hierarchy. Notably, these Tc cells were the most cross-reactive and the only effectors studied that lysed YF 1785 -pulsed targets as efficiently as other 1785 peptide-pulsed targets. This demonstrates that YF 1785 , despite its low affinity for K k , is present at sufficient density to sensitize target cells for lysis by appropriate Tc cells, despite its low affinity for K k . In contrast, anti-YF 1785 effectors displayed only very weak cytolytic activity against any of the targets used. All 1785 peptides, except the generally weak stimulator YF 1785 , generated effectors capable of lysing DEN 1971 -pulsed targets. These are striking data because in most cases only the C-terminal anchor residue is shared (Table I) 1971 , with any of the other 1971 peptides failed to provide evidence for such an antagonistic effect (data not shown).
Thus, in vitro restimulation of MVE-primed splenocytes was achieved with a range of peptides with varying degrees of sequence homology to the corresponding MVE-derived Tc cell determinants. The effectors generated were broadly peptide crossreactive, but there were many instances where peptide sequence homology did not correlate with cross-reactivity. Only YF 1785 and DEN 1971 failed to restimulate strong cytolytic activity against any of the targets tested. This suggests that their affinity for H-2K k (Table I) is too low to permit efficient in vitro restimulation. However, they could sensitize target cells for lysis, indicating that triggering effector function in Tc cells is less demanding than stimulation of clonal expansion over 5 days in vitro. Thus, the affinity of the peptides for K k seems to provide a better correlate for its immunogenicity (YF 1785 and DEN 1971 have the lowest affinity) than peptide-K k complex stability.
Anti-MVE memory Tc cells are peptide cross-reactive ex vivo
To guard against the possibility that the observed cross-reactivity was an artifact of the in vitro culture system, we used IFN-␥ production as a functional readout for in vivo-generated effector cells.
To prevent high anti-1971 peptide reactivity generated by MVE infection masking the possible cross-reactivity of anti-1785 Tc cells against 1971 peptides, we boosted MVE-primed mice (5 wk postinfection) with VV-C.NP 50 -57 /1785, a recombinant VV encoding the MVE 1785 peptide at the C-terminal position of an endoplasmic reticulum-targeted tandem peptide. Infection with this virus results in efficient, TAP-independent presentation of the MVE 1785 determinant (33) . Four days after challenge, freshly isolated splenocytes were incubated for 6 h with the panel of flavivirus-derived peptides. This protocol selectively stimulates MVE 1785 -reactive, but not MVE 1971 -reactive memory Tc cells (Fig. 2 and data not shown) . There was a clear, peptide-dependent hierarchy in the number of CD8 ϩ lymphocytes induced to produce IFN-␥ (Fig. 2) , similar to that of lysis of peptide-pulsed target cells by MVE-primed splenocytes stimulated in vitro with MVE 1785 (Table III k -bound peptides that had been eluted from two cell lines by others (49) were tested (Table IVA) . For MVE 1785 -like peptides, His at position 3 was considered important, with only conservative substitutions allowed at the anchor residues and at positions 5 and 7. This yielded a "1785-motif": x(ED)Hx(GA)x(ED)(VI), where "x" may represent any amino acid. For MVE 1971 -like peptides, we considered that G3 and V7 were most important (conservative substitutions permitted), because recognition of YF 1971 and failure to recognize NP 50 -57 indicated that positions 4 to 6 are neither sufficient nor required for recognition by at least some of the clones expanding (Table  IV , B and C). Three of the 1971 motif-containing peptides (indicated in Table IVC ) are probably of very low affinity for K k because they did not generate significant up-regulation of K k using the MHC class I stabilization assay. Nevertheless, they were included in the analysis because the data presented in Table III indicated that such peptides may still sensitize target cells for lysis. All other peptides tested in cytotoxicity assays induced intermediate or high up-regulation of K k in the stabilization assay (data not shown). None of the peptides was recognized on T2.K k target cells, suggesting an exquisite fine specificity of the Tc cells generated in MVE infection with regard to self-peptides. Furthermore, to test the possibility that the two K k anchors are sufficient for recognition by anti-MVE 1785 Tc cells, we also tested a heptamer and an octamer consisting of Gly residues except at the position 2 (Glu) and the C terminus (Ile). As expected, the octamer peptide was able to bind to K k , whereas the heptamer was not (data not shown). Neither of the two peptides was recognized by MVE 1785 -or MVE 1971 -reactive Tc cells (Table IVD) .
Target cells infected with viruses unrelated to flaviviruses are not recognized by anti-MVE Tc cells
Finally, we asked whether target cells infected by flavi-unrelated viruses are recognized by anti-MVE effectors. For analysis we chose influenza virus A and B, Sendai virus, SFV, and adenovirus-5. The data shown in Table V show no significant cross-reactivity on any targets infected with the unrelated viruses. The conditions for infection used have been shown in many previous experiments to be optimal to sensitize these targets for lysis by the relevant virus-immune Tc cells (35, 50, 51) . This is in addition to VV (25, 33) and influenza virus A/WSN (52, 53) , where lack of cross-reactivity has been shown previously.
Discussion
The data presented here illustrate the principle that the degree of amino acid sequence similarity between H-2K k -binding octamer peptide determinants is an unreliable predictor of Tc cell crossreactivity. Two immunodominant, K k -restricted Tc cell determinants, MVE 1785 (REHSGNEI) and MVE 1971 (DEGEGRVI), and a b Amino acid residues identical with the MVE-peptide residues are indicated by hyphens; those that are conservative substitutions are shown in smaller font. We were interested to determine whether peptide cross-reactivity seen in cytolytic assays performed with secondary Tc cells expanded over 5 days in vitro was also reflected at the level of IFN-␥ production in T cells primed by MVE infection and boosted in vivo with a recombinant VV encoding MVE 1785 . With this protocol, which restimulates only MVE 1785 -but not MVE 1971 -reactive memory Tc cells, reactivity against DEN 1971 was also observed. This substantiates the cross-reactivities seen in the cytotoxic response.
Given the extraordinary cross-reactivity between peptides sharing only the C-terminal anchor residue, and because of prominent anti-self activity seen in ex vivo and secondary anti-flavivirus Tc cell populations (30, 42, 52, 53), we investigated cross-reactivity on a panel of self-peptides known to be naturally present in K k (49) or a panel of putative self-peptides with motifs related to MVE 1785 or MVE 1971 (Table IV) . No cross-reactivity was seen with 10 known naturally presented self K k -binding peptides, even though four of them shared three residues, including the anchors, with either MVE 1971 or MVE 1785 , and one shared four residues with MVE 1971 . Similarly, no cross-reactivity was seen with five examples of MVE 1785 -like putative self-peptides, even though they shared two or three amino acids with MVE 1785 plus another two or three conservative substitutions, usually in the buried anchor residues at position 2 and at the C terminus. Another panel of 12 MVE 1971 -like putative self-peptides also gave no cross-reactivity, despite sharing up to four residues with MVE 1971 and with additional conservative substitutions in one to three additional positions. In addition, no cross-reactivity occurred with an octameric peptide possessing the K k anchor residues and glycine in all other positions. (The observed lack of binding of a similar but heptamer peptide strongly indicates that binding of octamer peptides to K k results in a stretched configuration of the peptide within the groove.) These results indicate that either thymic negative selection or peripheral tolerance induction maintained Tc cell tolerance during MVE infection with respect to a substantial sample of selfpeptides with potential cross-reactivity to the dominant viral peptides. As previously discussed (55), Ohno raised the issue of selfnonself discrimination with respect to minimal nonamer and octamer peptides binding to MHC class I molecules (56) . The analysis of Ohno was based on the assumption that amino acid sequence similarity was central to cross-reactivity between self and viral peptides. Our results show that this assumption is invalid for cross-reactivity between viral peptides. We also found no crossreactivity between Tc cells stimulated by MVE 1785 or MVE 1971 and target cells infected with influenza viruses A and B, human adenovirus type 5, Sendai virus, SFV, or ectromelia virus, all of a Specific lysis is calculated from a four-point (3-fold dilutions) logarithmic regression curve, interpolated at an E:T ratio of 10:1. which are known to stimulate K k -restricted Tc cell responses (Table V, and Refs. 25, 53) . Finally, the immunodominant influenza virus nucleoprotein determinant, NP 50 -57 , did not cross-react with the MVE peptides in either cytotoxicity or IFN-␥ assays, despite sharing four amino acids with MVE 1971 (plus a conservative substitution in the anchor residue at position 2) and two residues with MVE 1785 (plus a conservative substitution at position 2).
The lack of recognition of self-peptides with sequence similarity to MVE determinants as well as determinants presented by cells infected with viruses other than flaviviruses suggests that despite the high peptide cross-reactivity among flaviviruses Tc cell recognition is highly peptide-discriminatory, but primary sequence homology is not the crucial factor. Such evidence of structural similarity in the absence of sequence homology in proteins with similar functions has been found to be not uncommon (57) . These results emphasize the fact that viral peptides may cross-react with no sequence similarity in amino acid residues accessible to the TCR, strongly suggesting that the basis for cross-reactivity may include common conformational changes induced in the MHC class I ␣ helices following binding of the viral Tc cell determinants and their homologs from antigenically related viruses. Furthermore, self-tolerance can be maintained despite self-peptides sharing up to four amino acids with viral peptides that dominate antiviral Tc cell responses.
It may be significant that all the cross-reactive peptides are derived from one viral protein, NS3. Perhaps the relevant stretches of amino acids in NS3, despite their different sequences, have structural similarity imposed by NS3 structure/function, thus giving rise to conformational similarity in MHC class I when they are acting as peptide ligands.
